IBERE PHARMACEUTICALS's ticker is IBER and the CUSIP is G46843101. A total of 48 filers reported holding IBERE PHARMACEUTICALS in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $96,430 | +1.5% | 9,557 | 0.0% | 0.05% | -34.7% |
| Q3 2022 | $95,000 | +1.1% | 9,557 | 0.0% | 0.08% | +7.1% |
| Q2 2022 | $94,000 | -46.3% | 9,557 | -46.6% | 0.07% | -41.7% |
| Q1 2022 | $175,000 | +0.6% | 17,881 | 0.0% | 0.12% | +11.1% |
| Q4 2021 | $174,000 | +8.8% | 17,881 | +8.2% | 0.11% | -24.5% |
| Q3 2021 | $160,000 | – | 16,533 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |